XERS Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 4.36%

Insider Buying (Last 12 Months): $103,894.16

Insider Selling (Last 12 Months): $0.00

Xeris Biopharma Insider Trading History Chart

Xeris Biopharma Share Price & Price History

^$1.72

▼ -0.045 (-2.56%)

As of 04/25/2024 11:16 AM ET

Days: 30 | 90 | 365

How to camouflage a factory of 53,000 workers

From Stansberry Research | Ad

"If I Had To Pour Every Single Penny of My Retirement Into Just ONE STOCK..." The former Goldman Sachs VP – who called everything from Microsoft's 1,100% surge... to the death of the 60/40 portfolio – is now stepping forward with his most explicit message yet: "Make this ONE STOCK the cornerstone of your portfolio."

Get the full story here.

Xeris Biopharma Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/14/2024	John P Schmid	Director	Buy	4,500	$2.16	$9,720.00	11,000
11/27/2023	Jeffrey W Sherman	Director	Buy	5,400	$1.87	$10,098.00	5,400
11/17/2023	John Patrick Shannon Jr	Insider	Buy	30,769	$1.64	$50,461.16	1,408,575
11/16/2023	John P Schmid	Director	Buy	6,500	$1.51	$9,815.00	6,500
8/9/2023	Paul R. Edick	Insider	Buy	10,000	$2.38	$23,800.00	2,288,064
5/12/2022	Paul R. Edick	Insider	Buy	100,000	$1.40	$140,000.00	1,508,064
2/22/2022	Steven Prestrelski	Insider	Sell	11,228	$2.42	$27,171.76
11/15/2021	Paul R. Edick	Insider	Buy	20,000	$2.28	$45,600.00

Global crypto currency reset (41 major banks signed up)

From Stansberry Research | Ad

Behind closed doors, at least 41 major US banks have signed up to a strange new crypto project...

Here's everything you need to know.

SEC Filings (Institutional Ownership Changes) for Xeris Biopharma (NASDAQ:XERS)

42.75% of Xeris Biopharma stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Xeris Biopharma Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
4/18/2024	Diversified Trust Co	175,741	$0.39M	0.0%	+12.9%	0.125%
4/17/2024	Deltec Asset Management LLC	52,000	$0.12M	0.0%	-79.9%	0.037%
2/20/2024	Quarry LP	20,000	$47K	0.0%	N/A	0.014%
2/14/2024	Invenomic Capital Management LP	568,619	$1.34M	0.1%	N/A	0.412%
2/14/2024	CenterBook Partners LP	110,627	$0.26M	0.0%	N/A	0.080%
2/13/2024	Stonepine Capital Management LLC	5,937,000	$13.95M	6.0%	+0.4%	4.298%
2/13/2024	Tower Research Capital LLC TRC	27,848	$65K	0.0%	+53.7%	0.020%
2/12/2024	Eagle Asset Management Inc.	20,423	$48K	0.0%	N/A	0.015%
2/8/2024	Brown Advisory Inc.	211,405	$0.50M	0.0%	-7.9%	0.153%
2/8/2024	Panagora Asset Management Inc.	140,318	$0.33M	0.0%	-43.9%	0.102%
1/24/2024	China Universal Asset Management Co. Ltd.	15,973	$38K	0.0%	+351.1%	0.012%
1/22/2024	Deltec Asset Management LLC	259,246	$0.61M	0.1%	-17.8%	0.188%
1/12/2024	SG Americas Securities LLC	33,777	$79K	0.0%	+83.9%	0.024%
1/8/2024	Diversified Trust Co	155,650	$0.37M	0.0%	-11.3%	0.113%
11/15/2023	Annandale Capital LLC	25,000	$47K	0.0%	N/A	0.018%
11/15/2023	GSA Capital Partners LLP	381,231	$0.71M	0.1%	+1,047.8%	0.276%
11/14/2023	MPM Bioimpact LLC	3,987,967	$7.42M	2.0%	+0.3%	2.888%
11/14/2023	Alpine Global Management LLC	300,000	$0.56M	0.1%	+33.3%	0.217%
11/14/2023	Stonepine Capital Management LLC	5,915,372	$11M	3.7%	+7.5%	4.284%
11/7/2023	Barclays PLC	105,743	$0.20M	0.0%	+14.1%	0.077%
10/31/2023	Panagora Asset Management Inc.	250,200	$0.47M	0.0%	-13.0%	0.181%
10/25/2023	Brown Advisory Inc.	229,505	$0.43M	0.0%	-2.9%	0.166%
10/24/2023	Bank of New York Mellon Corp	412,943	$0.77M	0.0%	-2.7%	0.299%
10/24/2023	Cambridge Investment Research Advisors Inc.	35,670	$66K	0.0%	N/A	0.026%
10/23/2023	Deltec Asset Management LLC	315,246	$0.59M	0.1%	-22.4%	0.228%
10/13/2023	SG Americas Securities LLC	18,363	$34K	0.0%	N/A	0.013%
10/10/2023	Sinecera Capital LLC	253,101	$0.47M	0.6%	N/A	0.183%
8/15/2023	Caxton Corp	5,641,920	$14.78M	42.7%	-6.6%	4.086%
8/11/2023	Panagora Asset Management Inc.	287,600	$0.75M	0.0%	N/A	0.212%
8/10/2023	Cetera Advisor Networks LLC	110,837	$0.29M	0.0%	+6.3%	0.082%
8/7/2023	Principal Financial Group Inc.	45,290	$0.12M	0.0%	+202.6%	0.033%
8/3/2023	Mackenzie Financial Corp	25,978	$66K	0.0%	N/A	0.019%
7/31/2023	Strs Ohio	64,300	$0.17M	0.0%	N/A	0.047%
7/27/2023	Virtu Financial LLC	80,416	$0.21M	0.0%	+155.3%	0.059%
7/21/2023	Creative Planning	11,393	$30K	0.0%	N/A	0.008%
7/18/2023	Diversified Trust Co	175,407	$0.46M	0.0%	+12.7%	0.129%
7/18/2023	Deltec Asset Management LLC	406,190	$1.06M	0.2%	-34.7%	0.300%
5/15/2023	Rubric Capital Management LP	426,267	$0.70M	0.0%	N/A	0.315%
5/15/2023	Stonepine Capital Management LLC	8,640,205	$14.08M	4.7%	-22.8%	6.375%
5/9/2023	Goldstein Advisors LLC	25,425	$41K	0.0%	+64.8%	0.019%
5/1/2023	Virtu Financial LLC	31,498	$51K	0.0%	N/A	0.023%
4/28/2023	Van Hulzen Asset Management LLC	20,278	$33K	0.0%	N/A	0.015%
4/28/2023	SG Americas Securities LLC	40,947	$67K	0.0%	N/A	0.030%
4/17/2023	Deltec Asset Management LLC	622,072	$1.01M	0.3%	+68.6%	0.459%
3/23/2023	MetLife Investment Management LLC	25,829	$34K	0.0%	-63.5%	0.019%
1/25/2023	Deltec Asset Management LLC	368,926	$0.49M	0.1%	-31.4%	0.272%
11/15/2022	Kamunting Street Capital Management L.P.	75,000	$0.12M	0.2%	N/A	0.055%
11/14/2022	Armistice Capital LLC	2,504,431	$3.91M	0.1%	-57.0%	1.848%
11/10/2022	Stonepine Capital Management LLC	12,928,168	$20.17M	9.1%	+11.0%	9.539%
11/10/2022	ExodusPoint Capital Management LP	20,528	$32K	0.0%	-63.9%	0.015%
11/7/2022	Virtu Financial LLC	18,180	$28K	0.0%	-67.9%	0.013%
11/3/2022	Barclays PLC	60,745	$95K	0.0%	+105.3%	0.045%
10/31/2022	SG Americas Securities LLC	25,397	$40K	0.0%	N/A	0.019%
10/26/2022	Deltec Asset Management LLC	537,926	$0.84M	0.2%	+32.5%	0.397%
10/18/2022	Bailard Inc.	56,000	$87K	0.0%	N/A	0.041%
8/15/2022	Laurion Capital Management LP	20,756	$32K	0.0%	N/A	0.015%
8/11/2022	Yakira Capital Management Inc.	90,076	$0.14M	0.0%	-23.1%	0.066%
8/3/2022	AE Wealth Management LLC	79,787	$0.12M	0.0%	N/A	0.059%
8/1/2022	ProShare Advisors LLC	25,428	$39K	0.0%	+81.8%	0.019%
7/27/2022	Sinecera Capital LLC	253,101	$0.39M	0.4%	N/A	0.187%
7/19/2022	GPS Wealth Strategies Group LLC	65,025	$100K	0.0%	N/A	0.048%
7/18/2022	Deltec Asset Management LLC	406,000	$0.63M	0.1%	+63.7%	0.300%
5/16/2022	Granahan Investment Management LLC	405,247	$1.04M	0.0%	-22.8%	0.609%
5/12/2022	Yakira Capital Management Inc.	117,076	$0.30M	0.0%	N/A	0.176%
5/12/2022	Running Point Capital Advisors LLC	10,000	$26K	0.0%	N/A	0.015%
5/12/2022	Connor Clark & Lunn Investment Management Ltd.	28,897	$74K	0.0%	N/A	0.043%
5/11/2022	Whitener Capital Management Inc.	12,000	$30K	0.0%	N/A	0.018%
5/11/2022	GSA Capital Partners LLP	117,307	$0.30M	0.0%	+5.4%	0.176%
5/11/2022	CTC Capital Management LLC	11,800	$30K	0.1%	N/A	0.018%
5/9/2022	Brown Advisory Inc.	248,154	$0.64M	0.0%	-17.2%	0.373%
5/9/2022	Qube Research & Technologies Ltd	95,622	$0.25M	0.0%	-21.4%	0.144%
5/4/2022	Commonwealth Equity Services LLC	147,234	$0.38M	0.0%	-25.4%	0.221%
4/26/2022	Sciencast Management LP	35,934	$92K	0.0%	N/A	0.054%
4/21/2022	Zurcher Kantonalbank Zurich Cantonalbank	10,751	$28K	0.0%	N/A	0.016%
4/11/2022	Deltec Asset Management LLC	248,000	$0.64M	0.1%	-39.7%	0.373%
2/15/2022	Stonepine Capital Management LLC	5,656,373	$16.57M	7.6%	N/A	8.506%
2/15/2022	Kamunting Street Capital Management L.P.	64,539	$0.19M	0.1%	N/A	0.097%
2/14/2022	Evercore Wealth Management LLC	38,801	$0.11M	0.0%	N/A	0.058%
2/14/2022	Redmile Group LLC	1,046,587	$3.07M	0.1%	-23.0%	1.574%
2/14/2022	IHT Wealth Management LLC	342,897	$1.01M	0.1%	+2.6%	0.516%
2/14/2022	GSA Capital Partners LLP	111,272	$0.33M	0.0%	N/A	0.167%
2/10/2022	Qube Research & Technologies Ltd	121,627	$0.36M	0.0%	N/A	0.183%
2/10/2022	Rafferty Asset Management LLC	43,341	$0.13M	0.0%	+48.6%	0.065%
2/8/2022	Raymond James & Associates	11,300	$33K	0.0%	N/A	0.017%
2/8/2022	Northern Trust Corp	190,022	$0.56M	0.0%	+54.8%	0.286%
2/7/2022	Victory Capital Management Inc.	15,965	$47K	0.0%	N/A	0.024%
2/3/2022	Advisor Group Holdings Inc.	38,773	$0.11M	0.0%	+38.1%	0.058%
2/1/2022	FNY Investment Advisers LLC	49,088	$0.14M	0.1%	N/A	0.074%
2/1/2022	Qube Research & Technologies Ltd	121,627	$0.36M	0.0%	N/A	0.183%
1/31/2022	Ieq Capital LLC	50,169	$0.15M	0.0%	N/A	0.075%
1/31/2022	Commonwealth Equity Services LLC	197,234	$0.58M	0.0%	+102.1%	0.297%
1/27/2022	Brown Advisory Inc.	299,754	$0.88M	0.0%	N/A	0.451%
1/25/2022	Deltec Asset Management LLC	411,000	$1.20M	0.2%	-10.7%	0.618%
1/20/2022	AE Wealth Management LLC	59,666	$0.18M	0.0%	+29.5%	0.090%
1/13/2022	Veery Capital LLC	12,544	$37K	0.0%	N/A	0.019%
1/13/2022	Diversified Trust Co	155,650	$0.46M	0.0%	N/A	0.234%
1/10/2022	FNY Investment Advisers LLC	49,088	$0.14M	0.1%	N/A	0.074%
11/16/2021	Squarepoint Ops LLC	12,595	$31K	0.0%	-61.4%	0.019%
11/16/2021	Triumph Capital Management	21,350	$0.13M	0.1%	N/A	0.032%
11/15/2021	Man Group plc	36,400	$89K	0.0%	N/A	0.055%

Data available starting January 2016

Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies in Illinois. The company offers Gvoke, a ready-to-use liquid-stable glucagon for the treatment of severe hypoglycemia pediatric and adult patients; Keveyis, a therapy for the treatment of hyperkalemic, hypokalemic, and related variants of primary periodic paralysis; and Recorlev, a cortisol synthesis inhibitor proved for the treatment of endogenous hypercortisolemia in adult patients with Cushing's syndrome. It is also developing XP-8121, a once-weekly subcutaneous injection of levothyroxine that is in phase I clinical trial for the treatment of hypothyroidism; and non-aqueous XeriSol and XeriJect technologies for various therapies. The company was incorporated in 2005 and is headquartered in Chicago, Illinois.

Today's Range

Now: $1.72

$1.70

$1.76

50 Day Range

MA: $2.35

$1.74

$3.22

52 Week Range

Now: $1.72

$1.46

$3.26

Volume

278,505 shs

Average Volume

2,122,344 shs

Market Capitalization

$240.88 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.33

Who are the company insiders with the largest holdings of Xeris Biopharma?: Xeris Biopharma's top insider investors include:
Paul R Edick (Insider)
John Patrick Shannon Jr (Insider)
John P Schmid (Director)
Jeffrey W Sherman (Director)
Learn More about top insider investors at Xeris Biopharma.
Who are the major institutional investors of Xeris Biopharma?: Xeris Biopharma's top institutional investors include:
Diversified Trust Co — 0.13%
Deltec Asset Management LLC — 0.04%
Learn More about top institutional investors of Xeris Biopharma stock.
Which major investors are selling Xeris Biopharma stock?: During the last quarter, XERS stock was sold by these institutional investors:
Deltec Asset Management LLC
Which major investors are buying Xeris Biopharma stock?: Within the previous quarter, XERS stock was purchased by institutional investors including:
Diversified Trust Co
Within the previous year, these company insiders have bought Xeris Biopharma stock:
Paul R Edick (Insider)
John Patrick Shannon Jr (Insider)
John P Schmid (Director)
Jeffrey W Sherman (Director)
Learn More investors buying Xeris Biopharma stock.